Max Ventures and Industries’ arm acquires 85% stake in Pharmax

27 Nov 2019 Evaluate

Max Ventures and Industries’ wholly owned subsidiary -- Max Estates has completed acquisition of 85.17% equity share capital of Pharmax on November 25, 2019 for an aggregate consideration of Rs 60.73 crore, in terms of the Share Purchase Agreement executed amongst Max Estates, Max India, and Pharmax. Consequent to the completion of the acquisition, Pharmax has become a step down subsidiary of the company, through Max Estates.

Max Ventures and Industries, a part of the $3.2 billion Max Group, operates primarily in the areas of manufacturing and real estate.

Max Vent.-Amalgamat. Share Price

215.65 0.00 (0.00%)
10-Aug-2023 18:01 View Price Chart
Peers
Company Name CMP
Bajaj Finserv 1579.80
Paul Merchants 835.00
Data Infrastructure 162.00
IIFL Finance 522.15
Embassy Office Parks 356.20
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.